Austin Medical Technologies, Inc. Experiences Double Digit Growth of 22% in 1st Quarter 2005 over Prior Quarter in 2004.

ATLANTA -- In the first paragraph of the press release the value of new business in the 1st quarter was misstated. It should be $370,000.

The corrected release reads:

AUSTIN MEDICAL TECHNOLOGIES, INC. EXPERIENCES DOUBLE DIGIT GROWTH OF 22% IN 1ST QUARTER 2005 OVER PRIOR QUARTER IN 2004

AUSTIN MEDICAL TECHNOLOGIES, Inc. (PINK SHEETS:AMTK), announces sales grew by a double digit growth of 22% in the 1st quarter of 2005 over the prior 1st quarter of 2004 representing $370,000 in new business.

Kurt Tarter, President and CEO, states, "Our business continues to experience strong and steady growth due to the continued demand for our products and services utilized in the fastest growing segment of health care where surgical procedures are performed; Outpatient Surgery Centers. Our business is a recurring revenue business with 95% contract retention year after year. We look to continue this strong growth throughout 2005."

About Austin Medical Technologies, Inc./eyeDirecti(TM) (Brand)

Austin Medical Technologies delivers "DIRECT" from the manufacturer to the Surgeon, the only technology based, "Single Source Supply Solution" for custom sterile surgery trays made up of 80% of all disposable surgical devices utilized in surgery. Currently the company has contracted with 200 eye surgery centers including the 2 largest eye surgery centers in the USA.

The ASC market for custom sterile surgery trays is a $2.1 Billion market. Austin Medical is dedicated exclusively to the Ambulatory Surgery Center (ASC) market aka Outpatient Surgery Centers, consisting of 12,000 surgery centers with 40,000 surgeons performing over 30,000,000 surgeries annually. Ambulatory Surgery Centers (ASC) refers to surgical centers where surgery is performed on an outpatient basis not requiring an over night stay.

Note: Any statements released by Austin Medical Technologies, Inc, or any of its affiliates that are forward- looking, are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act. Editors and investors are cautioned that forward-looking statements invoke risk and uncertainties that may affect the Company's business prospects and performances. These include economic, competitive, governmental, technological and other factors discussed in the statements.